speb/financial-data huggingface dataset:
JGCHEM.NS income_statement (annual, 2023-03-31) — Minority Interests: -18490000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Net Debt: 668030000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -1670000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Net Income: 549430000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 549430000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 567930000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 549430000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 549430000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 766940000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 567930000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Net Interest Income: -51060000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 47040000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -235900000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 11200000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -51060000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -10000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -10000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Net PPE: 361910000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -98680000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -247100000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 2076450000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 5890000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 2850000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 18780000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 806610000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Normalized Income: 519653921.95
JGCHEM.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 311690000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Operating Income: 726620000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Operating Revenue: 7845520000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 39186063.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: -10000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: -10000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 20000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 100000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 3000000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 47370000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 10000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: -10000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 2530000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 425890000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Payable: 27570000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 19940000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 130890000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Other Special Charges: -1210000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Payables: 117580000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 3030000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 12630000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 92430000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Pretax Income: 766940000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 0.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -177500000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -98900000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 739920000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 6399130000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 34410000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 20220000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 20220000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -28800000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: 0.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 78740000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 1707280000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 224540000.00
JGCHEM.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 220000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 94790000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 125200000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Share Issued: 39186063.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Special Income Charges: -1080000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 2076550000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 2076450000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 10433921.95
JGCHEM.NS income_statement (annual, 2023-03-31) — Tax Provision: 199010000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.26
JGCHEM.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -195420000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Assets: 2977900000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 2143710000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Debt: 703510000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 2135280000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Total Expenses: 7118900000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 842620000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 414550000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 75890000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 8050000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 6330000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 40210000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 40210000.00
JGCHEM.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1796620000.00
JGCHEM.NS income_statement (annual, 2023-03-31) — Write Off: 2290000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — +Operating Expense: 697780000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — +Total Revenue: 6676710000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 82110000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1166880000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -144130000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 1479290000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -960000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 45260000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 78300000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 32148381.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Basic EPS: 9.60
JGCHEM.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 35480000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 160530000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -94540000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 391860000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 466930000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 1787680000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 230000000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 236930000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 481900000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -115890000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Change In Payable: 11940000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -10200000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 367750000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 431430000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Common Stock: 391860000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 3983940000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 1521640000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 0.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 5566500000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Current Assets: 3938870000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Current Debt: 101670000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 101670000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 394520000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 15020000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Depreciation: 45260000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 45260000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 32148381.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Diluted EPS: 9.60
JGCHEM.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 308560000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 70000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — EBIT: 464180000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — EBITDA: 509440000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 20000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — End Cash Position: 466930000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 33720000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 1070310000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 293360000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 665100000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -11830000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -60000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 24420000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 190000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 1167840000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 561060000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Gross Profit: 1110210000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 4150000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Interest Expense: 33160000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 33160000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Interest Income: 6100000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 6100000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -38030000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 1840000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Inventory: 556550000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 4121710000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -1398520000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 112020000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 1521640000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 0.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 41080000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 36100000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 36100000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 0.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -31060000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 4130000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 359450000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 71140000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Minority Interests: -12520000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 1521640000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -2140000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Net Income: 308560000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 308560000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 321080000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 308560000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 308560000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 449040000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 321080000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Net Interest Income: -33970000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -1306020000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -565740000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -31060000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -33970000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 152440000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 10000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Net PPE: 416930000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -94420000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -534680000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 3983750000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 6510000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 0.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 4130000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 10630000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 504690000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Normalized Income: 305021579.51
JGCHEM.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 759640000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Operating Income: 412430000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Operating Revenue: 6676710000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 39186063.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: 20000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: -30000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 900000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 3592080000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 190000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 30220000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 170000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: -10000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 4480000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 375330000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Payable: 189230000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Properties: 416930000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 6570000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 1320750000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Other Special Charges: 17960000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Payables: 276850000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: 3970000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15020000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 249350000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Pretax Income: 431020000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 960000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -2010870000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -94540000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 263190000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 5566500000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 45260000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 22970000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 22970000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -31060000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 167720000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 2013540000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 704850000.00
JGCHEM.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 120000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 109770000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 134190000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Share Issued: 39186063.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Special Income Charges: -17960000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 3983940000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 3983750000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 1211579.51
JGCHEM.NS income_statement (annual, 2024-03-31) — Tax Provision: 109940000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.26
JGCHEM.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -122670000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Assets: 4489820000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 4020040000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Debt: 137770000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 4055080000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Total Expenses: 6264280000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 434740000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 550940000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 40220000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 6910000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 5510000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 4750000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 4750000.00
JGCHEM.NS balance_sheet (annual, 2024-03-31) — Working Capital: 3544350000.00
JGCHEM.NS income_statement (annual, 2024-03-31) — Write Off: 0.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 70030000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 1286070000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 191020000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 391860000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 312250000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 1770210000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 391860000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 4362470000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 3310000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 4163710000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 127550000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 127550000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 307060000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 12210000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 150000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 405280000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 645350000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 4491230000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 191020000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 1210000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1210000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 4860000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 84590000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 405280000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 4362320000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 0.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 5430000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 39186063.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 462080000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 11970000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 3970610000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 5470000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 401970000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1457960000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Payables: 103550000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 39186063.00
JGCHEM.NS income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 4362470000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 4362320000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 4765620000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 4363680000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 128760000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 4447060000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 318560000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 601920000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 11500000.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 33520000.00
JGCHEM.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
JGCHEM.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
JGCHEM.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 3856650000.00
JGCHEM.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 24680000.00
JGCHEM.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
JGCHEM.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
JGCHEM.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
JGCHEM.NS income_statement (annual, 2025-03-31) — +Operating Expense: 879860000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 216360000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — +Total Revenue: 8479440000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2242540000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 166010000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 166010000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 1418520000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1418520000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -178390000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -178390000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 1479290000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1479290000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -970000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -970000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 53810000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 104400000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 104400000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 39176867.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 39145408.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Basic EPS: 16.34
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 3.92
JGCHEM.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 466930000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 167020000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 167020000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -46900000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 391860000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 391860000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 313770000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 313770000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1443520000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1443520000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 200000000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 200000000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 113770000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 113770000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -557890000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -8690000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Change In Payable: 77930000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -250110000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -738760000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -153150000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Common Stock: 391860000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 391860000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 4647510000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 4647510000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 0.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 10920000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 10920000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 6792240000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1845060000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Current Assets: 4440400000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 4440400000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Current Debt: 1510000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 1510000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1510000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1510000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 223080000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 223080000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 18920000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 18920000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Depreciation: 53810000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 53810000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 39176867.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 39145408.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Diluted EPS: 16.34
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 3.92
JGCHEM.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 640150000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 153450000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 60000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — EBIT: 907470000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — EBIT: 216470000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — EBITDA: 961280000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — EBITDA: 216470000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — End Cash Position: 313770000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 17440000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 17440000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -288780000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 242300000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 242300000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -158870000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -26970000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 660000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 42460000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 130000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 130000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 1419490000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1419490000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 578370000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 578370000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Gross Profit: 1687200000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 397480000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 2830000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 2830000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Interest Expense: 8470000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 950000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 8470000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 950000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Interest Income: 84380000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 84380000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -9180000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 53310000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Inventory: 1114440000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 1114440000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 4649510000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 4649510000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: 247600000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 121840000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 121840000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 0.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 41080000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 41080000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 490000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 490000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 490000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 490000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -35600000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 4490000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 4490000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 359350000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 359350000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 98620000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 98620000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Minority Interests: -27440000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Minority Interests: -5610000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -3160000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Net Income: 640150000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income: 153450000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 640150000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 153450000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 667600000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 159070000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 640150000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 153450000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 640150000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 153450000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 899000000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 667590000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 159060000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Net Interest Income: -8470000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -950000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 240110000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -135770000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -35600000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -8470000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -950000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -14530000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Net PPE: 399980000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 399980000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -45880000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -100170000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 4647380000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 4647380000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 0.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 0.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 5110000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 5110000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 4490000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 4490000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 16940000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 16940000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 961280000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 216470000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Normalized Income: 640150000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 153450000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -111970000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Operating Income: 807340000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Operating Income: 181120000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Operating Revenue: 8479440000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 2242540000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 39186063.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 39186063.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: -10000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 277450000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 277450000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 880000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 880000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 4255650000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 4255650000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 130000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 130000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -75910000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 10000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 10000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 100120000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 35350000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 695780000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 172590000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Payable: 33020000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 33020000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Properties: 389060000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 389060000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 36260000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 36260000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 1129750000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1129750000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Other Special Charges: 660000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Payables: 201320000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Payables: 201320000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 5720000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 18920000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 18920000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 279400000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 279400000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Pretax Income: 899000000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 215520000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 640000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -917180000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -46900000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 872140000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 872140000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 6792240000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1845060000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 53810000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 21820000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 21820000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -35600000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 145430000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 145430000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 2653690000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2653690000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 1157290000.00
JGCHEM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 1020000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 118120000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 160580000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 39186063.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 39186063.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Special Income Charges: -780000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: -780000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 4647510000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 4647510000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 4647380000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 4647380000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Tax Provision: 231400000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 56450000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.26
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.26
JGCHEM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -227100000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 4979300000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 4979300000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 4648000000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4648000000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 2000000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 2000000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 4746130000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 4746130000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Total Expenses: 7672100000.00
JGCHEM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 2061420000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 233170000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 233170000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 538900000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 538900000.00
JGCHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 10090000.00
JGCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 10090000.00
JGCHEM.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 6210000.00